Liling Q. Zhang

Union Hospital
Wuhan, 430022, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 99 publications

Root fracture of maxillary young permanent central incisor with mandibular fracture: a case report

Root fracture of maxillary young permanent central incisor with mandibular fracture: a case report

Journal: Zhonghua kou qiang yi xue za zhi = Zhonghua kouqiang yixue zazhi = Chinese journal of stomatology
Published: April 29, 2026

Total marrow irradiation-based conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A multicenter real-world study.

Total marrow irradiation-based conditioning for allogeneic hematopoietic stem cell transplantation in patients with hematologic malignancies: A multicenter real-world study.

Journal: Cell transplantation
Published: April 17, 2026

Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study.

Upfront Autologous Stem Cell Transplantation in First Complete Remission for Advanced-Stage Extra-Nodal NK/T-Cell Lymphoma: A Multicenter Retrospective Study.

Journal: American journal of hematology
Published: February 19, 2026

Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment-naive peripheral T-cell lymphoma: A multicenter, open-label, single-arm, phase 1b trial.

Combination of mitoxantrone hydrochloride liposome with cyclophosphamide, vincristine, and prednisone for patients with treatment-naive peripheral T-cell lymphoma: A multicenter, open-label, single-arm, phase 1b trial.

Journal: Cancer
Published: December 01, 2025

Impact of handgrip strength on postoperative recovery and prognosis in elderly patients with intertrochanteric fractures.

Impact of handgrip strength on postoperative recovery and prognosis in elderly patients with intertrochanteric fractures.

Journal: Frontiers in medicine
Published: October 14, 2025

Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma.

Phase 1 study of zanubrutinib plus lenalidomide for patients with relapsed/refractory diffuse large B-cell lymphoma.

Journal: Blood advances
Published: September 18, 2025

Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26).

Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26).

Journal: Blood cancer journal
Published: August 21, 2025

Glutathione S-transferase inhibitor NBDHEX induces ROS-dependent immunogenic cell death and enhances PD-1 blockade in DLBCL.

Glutathione S-transferase inhibitor NBDHEX induces ROS-dependent immunogenic cell death and enhances PD-1 blockade in DLBCL.

Journal: Cell communication and signaling : CCS
Published: August 07, 2025

Retrospective analysis of clinical characteristics, treatment outcomes and prognosis of patients with natural killer/T-cell lymphoma.

Retrospective analysis of clinical characteristics, treatment outcomes and prognosis of patients with natural killer/T-cell lymphoma.

Journal: Oncology letters
Published: June 07, 2025

Clinical application of 90-gene expression test in a patient with occult breast cancer: a case report and literature review.

Clinical application of 90-gene expression test in a patient with occult breast cancer: a case report and literature review.

Journal: Breast cancer (Tokyo, Japan)
Published: April 04, 2025

Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review.

Multiple drug resistance caused by germline mutation of exon 27 of BRCA2 gene in triple-negative breast cancer: a case report and literature review.

Journal: Frontiers in oncology
Published: March 30, 2025

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study.

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study.

Journal: EClinicalMedicine
Published: March 29, 2025
Showing 1-12 of 99

Last Updated: 09/26/2026